59 related articles for article (PubMed ID: 27279974)
1. Methotrexate Use and Risk of Interstitial Lung Disease in Dermatomyositis.
Shah JT; Richardson WM; Mittal L; Castillo R; Mazori DR; Caplan AS; Femia AN
JAMA Dermatol; 2024 Jun; 160(6):676-678. PubMed ID: 38691354
[TBL] [Abstract][Full Text] [Related]
2. Clinical Images: Epistaxis may be a warning sign of lymphoproliferative disorder during methotrexate treatment for dermatomyositis.
Ishigaki S; Kajio N; Okayama M; Orikasa H; Tanaka S; Yoshikawa N; Taguchi H
ACR Open Rheumatol; 2024 Mar; 6(3):123. PubMed ID: 38117905
[No Abstract] [Full Text] [Related]
3. Neurological Involvement in the Course of Scleromyxedema: A Case Report.
Spagnolo F; Nozzoli C; Rini A; La Spada S; De Marco V; Passarella B
J Stroke Cerebrovasc Dis; 2016 Sep; 25(9):e148-50. PubMed ID: 27282303
[TBL] [Abstract][Full Text] [Related]
4. Methotrexate-induced panniculitis in a patient with rheumatoid arthritis.
Al Maashari R; Hamodat MM
Acta Dermatovenerol Alp Pannonica Adriat; 2016 Dec; 25(4):79-81. PubMed ID: 28006881
[TBL] [Abstract][Full Text] [Related]
5. [Panniculitis in patient undergoing treatment for dermatomyositis with methotrexate].
Pan African Medical Journal
Pan Afr Med J; 2020; 36():57. PubMed ID: 32582406
[TBL] [Abstract][Full Text] [Related]
6. Panniculitis in juvenile dermatomyositis.
Ghali FE; Reed AM; Groben PA; McCauliffe DP
Pediatr Dermatol; 1999; 16(4):270-2. PubMed ID: 10469409
[TBL] [Abstract][Full Text] [Related]
7. [Panniculitis in patient undergoing treatment for dermatomyositis with methotrexate].
Feki NB; Khanfir MS; Ghorbel IB; Said F; Houman MH
Pan Afr Med J; 2016; 23():149. PubMed ID: 27279974
[TBL] [Abstract][Full Text] [Related]
8. Panniculitis associated with dermatomyositis and recurrent ovarian cancer.
Girouard SD; Velez NF; Penson RT; Massarotti EM; Vleugels RA
Arch Dermatol; 2012 Jun; 148(6):740-4. PubMed ID: 22431715
[TBL] [Abstract][Full Text] [Related]
9. Panniculitis associated with amyopathic dermatomyositis.
Azevedo PO; Castellen NR; Salai AF; Barbosa FS; Alves CAXM; Pinto CAL
An Bras Dermatol; 2018; 93(1):119-121. PubMed ID: 29641712
[TBL] [Abstract][Full Text] [Related]
10. Methotrexate nodulosis.
Jang KA; Choi JH; Moon KC; Yoo B; Sung KJ; Koh JK
J Dermatol; 1999 Jul; 26(7):460-4. PubMed ID: 10458088
[TBL] [Abstract][Full Text] [Related]
11. Dermatomyositis panniculitis: a case report.
Carroll M; Mellick N; Wagner G
Australas J Dermatol; 2015 Aug; 56(3):224-6. PubMed ID: 24689899
[TBL] [Abstract][Full Text] [Related]
12. Low-dose methotrexate administered weekly is an effective corticosteroid-sparing agent for the treatment of the cutaneous manifestations of dermatomyositis.
Kasteler JS; Callen JP
J Am Acad Dermatol; 1997 Jan; 36(1):67-71. PubMed ID: 8996263
[TBL] [Abstract][Full Text] [Related]
13. Panniculitis in a patient on methotrexate for mixed connective tissue disease.
Nézondet-Chetaille AL; Brondino-Riquier R; Villani P; Bouvenot G
Joint Bone Spine; 2002 May; 69(3):324-6. PubMed ID: 12102282
[TBL] [Abstract][Full Text] [Related]
14. Panniculitis: a cutaneous manifestation of dermatomyositis.
Solans R; Cortés J; Selva A; Garcia-Patos V; Jimenez FJ; Pascual C; Bosch J; Vilardell M
J Am Acad Dermatol; 2002 May; 46(5 Suppl):S148-50. PubMed ID: 12004297
[TBL] [Abstract][Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
